The company's patented biosensor platform uses a small drop of saliva to provide high-quality, cost-effective results in approximately five minutes and can quantitatively detect disease biomarkers even present in low quantity. They are currently developing testing devices for THC and COVID-19, with potential for accurate and quantitative testing for alcohol, other drugs of abuse, and infectious diseases. RICOVR is based in Princeton, NJ, and has partnerships with leading research institutions and medical device manufacturing companies. Their team includes experts across medical device design and manufacturing, leadership, sales, medicine, technology, and scientific research committed to improving human health outcomes by transforming point-of-care diagnostics.